Early Detection is Better than Cure.
Ablesen manufactures medical device that detects critical or genetic diseases for early intervention. Our device, NACOTS, has efficacy rate on par with lab facilities while costing 95% cheaper.
Our Flagship Product
NACOTS
We leverage our expertise in IoT, circuitry, and biomedicine to tackle the decades-long problem of early disease detection. The result is Nucleic Acid Sensor Coupled with IoT System (NACOTS), a handheld device that can detect incidences of genetic diseases, or cancer cells, within minutes.
Disease Detection
NACOTS facilitate cost-effective detection of COVID-19, BRCA, cancer, and other critical diseases, enabling early intervention.
Genetic Markers Identification
We’re a better alternative to medical laboratories, for detection of hereditary diseases in children as early as 2 years old.
Support Group
With a network of government facilities, care centers, and community clinics, we enable support group for early disease intervention.
Why NACOTS
Cost-Effective
90% cheaper than institutional lab testing for early genetic disease detection.
Non-Invasive
Simple procedures using only blood samples.
High Efficacy
Early tests indicate 80%+ efficacy rate for detecting COVID-19
Expanding Ecosystem
We're collaborating with public & private clinics to enhance early disease intervention procedures.
Management Team
Our team begins as a research group under EMaS UiTM, consisting of experts from various fields of medicinal technologies.
Prof Zainiharyati Mohd Zin
Chief Executive Officer
Dr Yusairie Mohd
Chief Operating Officer
Afiq Ghani
Chief Technology Officer
Specialist Consultants
Prof Teddy Surya Gunawan
Senior Consultant
Prof Dr Anis Nurashikin Nordin
Microelectronics & Microfluidics
Dr Shihabuddin Ahmad Nordeen
Microbiologist
Assoc. Prof Dr Lim Ying Chin
Material Chemistry
Dr Nur Farhana Hamzah
MB Bch BAO (Ireland)
Our Office
Faculty of Applied Sciences
Universiti Teknologi MARA (UiTM)
40450 Shah Alam, Selangor
Call Us
+603 5544 4560
Email Us
zainihar@uitm.edu.my